• The company is scheduling an Analyst/Investor Meeting as part of the JP Morgan India Conference to be held on Monday, September 21, 2026 in Mumbai.
  • The meeting will be conducted in in-person mode and will be of One to One type with institutional investors and analysts.
  • The meeting is scheduled to begin at 10:00 A.M. onwards, though the disclosure notes that the schedule is subject to changes due to exigencies on the part of analysts/investors.
  • The purpose of the meeting is standard investor relations engagement, though no specific financial period or strategic topics are explicitly mentioned for discussion.
  • Management participants are not specifically listed in this disclosure.
  • The company will make a presentation available for the meeting at the following URL: https://d28c6jni2fmamz.cloudfront.net/8ECPQ1FY27_8dec5fbe94.pdf
  • The presentation and this disclosure will also be available on the company's website at www.starhealth.in
  • The disclosure is made in compliance with Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which implies standard compliance with non-disclosure of UPSI requirements.

Additional Notes Section

  • This is a standard regulatory intimation of an investor meeting without attached financial presentations or detailed agendas.
  • No financial data, performance metrics, or strategic updates are disclosed in this announcement.
  • The document is signed by Jayashree Sethuraman, Company Secretary & Compliance Officer, indicating proper corporate governance procedures.
  • The reference number for the disclosure is SHAI/B & S/SE/110/2026-27 dated September 15, 2026 from Chennai.